L. Azoulay

First name
L.
Last name
Azoulay
Lu, S., Yin, H., H. Y. Yu, O., & Azoulay, L. (2022). Incretin-Based Drugs and the Incidence of Prostate Cancer Among Patients with Type 2 Diabetes. Epidemiology. http://doi.org/10.1097/ede.0000000000001486
View
Chowdhury, R., Michaud, J., H. Y. Yu, O., Yin, H., Azoulay, L., & Renoux, C. (2022). Effectiveness and safety of apixaban vs. rivaroxaban in patients with atrial fibrillation and type 2 diabetes mellitus. Thromb Haemost. http://doi.org/10.1055/a-1798-2116
View
Pradhan, R., Yu, O., Platt, R. W., & Azoulay, L. (2022). Long-Term patterns of cancer incidence among patients with and without type 2 diabetes in the United Kingdom. Diabetes Res Clin Pract, 185, 109229. http://doi.org/10.1016/j.diabres.2022.109229
View
Pradhan, R., Yin, H., Yu, O., & Azoulay, L. (2022). Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Nonalcoholic Fatty Liver Disease Among Patients With Type 2 Diabetes. Diabetes Care. http://doi.org/10.2337/dc21-1953
View
Pradhan, R., Patorno, E., Tesfaye, H., Schneeweiss, S., Yin, H., Franklin, J., et al. (2022). Glucagon-Like Peptide-1 Receptor Agonists and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: Multisite Population-Based Cohort Study. Am J Epidemiol. http://doi.org/10.1093/aje/kwac021
View
Azoulay, L., Schneider-Lindner, V., Dell'Aniello, S., Filion, K. B., & Suissa, S. (2010). Thiazolidinediones and the risk of incident strokes in patients with type 2 diabetes: a nested case-control study. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.1883
View
Azoulay, L., Yin, H., Renoux, C., & Suissa, S. (2011). The use of atypical antipsychotics and the risk of breast cancer. Breast Cancer Res Treat. http://doi.org/10.1007/s10549-011-1506-2
View
Azoulay, L., Schneider-Lindner, V., Dell'Aniello, S., Schiffrin, A., & Suissa, S. (2010). Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.1834
View
Azoulay, L., Dell'Aniello, S., Huiart, L., Fort, G. G. du, & Suissa, S. (2011). Concurrent use of tamoxifen with CYP2D6 inhibitors and the risk of breast cancer recurrence. Breast Cancer Res Treat. http://doi.org/10.1007/s10549-010-1162-y
View
Azoulay, L., Yin, H., Benayoun, S., Renoux, C., Boivin, J. F., & Suissa, S. (2011). Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer. Eur Urol. http://doi.org/10.1016/j.eururo.2011.08.041
View